Skip to content

Author

Sarah Alsafi

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Development and validation of a nomogram predicting pathologic complete response to neoadjuvant chemotherapy in luminal type breast cancer patients using MammaPrint® and clinicopathological factor

Purpose Pathological complete response (pCR) of neoadjuvant chemotherapy (NACT) is the most important predictor of successful treatment in locally advanced breast cancer and is associated with survival outcomes. The aim of our study is to investigate a validated nomogram that predicted MammaPrint® to assess the respons...

Sarah Alsafi, T. Yoo, J. Kim et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.